• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

烟酸用于治疗血脂异常的临床进展

Clinical update on the use of niacin for the treatment of dyslipidemia.

作者信息

Berra Kathy

机构信息

Stanford Prevention Research Center, California, USA.

出版信息

J Am Acad Nurse Pract. 2004 Dec;16(12):526-34. doi: 10.1111/j.1745-7599.2004.tb00432.x.

DOI:10.1111/j.1745-7599.2004.tb00432.x
PMID:15645997
Abstract

PURPOSE

To provide nurse practitioners (NPs) with clinical and practical information about the use of niacin in the treatment of dyslipidemia.

DATA SOURCES

Research-based and review articles in the medical literature and National Cholesterol Education Program guidelines.

CONCLUSIONS

Niacin provides beneficial effects on all major lipid fractions, particularly high-density lipoprotein cholesterol and triglycerides. Niacin also reduces low-density lipoprotein (LDL) cholesterol; lipoprotein (a); and the number of highly atherogenic small, dense LDL particles. Niacin promotes angiographic regression when used in combination with other drugs that lower LDL cholesterol and can reduce cardiovascular risk in patients with coronary heart disease. Several niacin formulations are available, but the safety (i.e., from hepatotoxicity) and tolerability (i.e., severity of flushing) of these niacin formulations may differ.

IMPLICATIONS FOR PRACTICE

Niacin therapy is appropriate for many types of lipid abnormalities, including complex dyslipidemias. NPs can take several steps to minimize potential side effects of niacin therapy and to ensure that patients adhere to this important intervention.

摘要

目的

为执业护士提供有关烟酸在血脂异常治疗中应用的临床及实用信息。

数据来源

医学文献中的基于研究的文章和综述文章以及国家胆固醇教育计划指南。

结论

烟酸对所有主要脂质成分均有有益作用,尤其是高密度脂蛋白胆固醇和甘油三酯。烟酸还可降低低密度脂蛋白(LDL)胆固醇、脂蛋白(a)以及具有高度致动脉粥样硬化性的小而密LDL颗粒的数量。烟酸与其他降低LDL胆固醇的药物联合使用时可促进血管造影显示的病变消退,并可降低冠心病患者的心血管风险。有几种烟酸制剂可供选择,但这些烟酸制剂的安全性(即肝毒性方面)和耐受性(即潮红的严重程度)可能有所不同。

对实践的启示

烟酸治疗适用于多种类型的脂质异常,包括复杂的血脂异常。执业护士可采取多个步骤以尽量减少烟酸治疗的潜在副作用,并确保患者坚持这一重要干预措施。

相似文献

1
Clinical update on the use of niacin for the treatment of dyslipidemia.烟酸用于治疗血脂异常的临床进展
J Am Acad Nurse Pract. 2004 Dec;16(12):526-34. doi: 10.1111/j.1745-7599.2004.tb00432.x.
2
Niacin for dyslipidemia: considerations in product selection.用于血脂异常的烟酸:产品选择的考量因素
Am J Health Syst Pharm. 2003 May 15;60(10):995-1005. doi: 10.1093/ajhp/60.10.995.
3
Niacin as a component of combination therapy for dyslipidemia.烟酸作为血脂异常联合治疗的一种成分。
Mayo Clin Proc. 2003 Jun;78(6):735-42. doi: 10.4065/78.6.735.
4
Niacin-based therapy for dyslipidemia: past evidence and future advances.基于烟酸的血脂异常治疗:过去的证据与未来的进展
Am J Manag Care. 2002 Sep;8(12 Suppl):S315-22.
5
Lovastatin and extended-release niacin combination product: the first drug combination for the management of hyperlipidemia.洛伐他汀与缓释烟酸复方制剂:首款用于治疗高脂血症的复方药物。
Heart Dis. 2002 Mar-Apr;4(2):124-37. doi: 10.1097/00132580-200203000-00010.
6
Long-term safety and efficacy of a combination of niacin extended release and simvastatin in patients with dyslipidemia: the OCEANS study.烟酸缓释片与辛伐他汀联合应用于血脂异常患者的长期安全性和疗效:OCEANS研究
Am J Cardiovasc Drugs. 2008;8(2):69-81. doi: 10.2165/00129784-200808020-00001.
7
New developments in the use of niacin for treatment of hyperlipidemia: new considerations in the use of an old drug.烟酸用于治疗高脂血症的新进展:对一种老药应用的新思考。
Coron Artery Dis. 1996 Apr;7(4):321-6. doi: 10.1097/00019501-199604000-00009.
8
Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia.烟酸缓释剂与洛伐他汀治疗高胆固醇血症和混合性血脂异常
Ann Pharmacother. 2003 Jan;37(1):106-15. doi: 10.1345/aph.1C161.
9
A new extended-release niacin (Niaspan): efficacy, tolerability, and safety in hypercholesterolemic patients.一种新型缓释烟酸(Niaspan):在高胆固醇血症患者中的疗效、耐受性及安全性
Am J Cardiol. 1998 Dec 17;82(12A):29U-34U; discussion 39U-41U. doi: 10.1016/s0002-9149(98)00732-2.
10
Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial.每日一次服用烟酸治疗2型糖尿病相关血脂异常的疗效、安全性及耐受性:烟酸缓释片试验中糖尿病控制评估与疗效评价结果
Arch Intern Med. 2002 Jul 22;162(14):1568-76. doi: 10.1001/archinte.162.14.1568.